- Home
- LDWY vs PPBT Comparison
LDWY vs PPBT Comparison
Compare LDWY & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- PPBT
- Stock Information
- Founded
- LDWY 1990
- PPBT 2010
- Country
- LDWY United States
- PPBT Israel
- Employees
- LDWY N/A
- PPBT N/A
- Industry
- LDWY Advertising
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- LDWY Consumer Discretionary
- PPBT Health Care
- Exchange
- LDWY Nasdaq
- PPBT Nasdaq
- Market Cap
- LDWY 8.2M
- PPBT 8.7M
- IPO Year
- LDWY 1991
- PPBT N/A
- Fundamental
- Price
- LDWY $4.11
- PPBT $3.00
- Analyst Decision
- LDWY
- PPBT Strong Buy
- Analyst Count
- LDWY 0
- PPBT 2
- Target Price
- LDWY N/A
- PPBT $126.50
- AVG Volume (30 Days)
- LDWY 5.6K
- PPBT 38.0K
- Earning Date
- LDWY 03-31-2025
- PPBT 03-04-2025
- Dividend Yield
- LDWY N/A
- PPBT N/A
- EPS Growth
- LDWY N/A
- PPBT N/A
- EPS
- LDWY N/A
- PPBT N/A
- Revenue
- LDWY $31,581,000.00
- PPBT N/A
- Revenue This Year
- LDWY N/A
- PPBT N/A
- Revenue Next Year
- LDWY N/A
- PPBT N/A
- P/E Ratio
- LDWY N/A
- PPBT N/A
- Revenue Growth
- LDWY N/A
- PPBT N/A
- 52 Week Low
- LDWY $3.02
- PPBT $2.00
- 52 Week High
- LDWY $6.88
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- LDWY 47.81
- PPBT 40.77
- Support Level
- LDWY $4.13
- PPBT $3.12
- Resistance Level
- LDWY $4.55
- PPBT $3.37
- Average True Range (ATR)
- LDWY 0.22
- PPBT 0.24
- MACD
- LDWY -0.02
- PPBT -0.01
- Stochastic Oscillator
- LDWY 39.98
- PPBT 21.93
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.